Moderna Scales Down Manufacturing

Moderna Scales Down Manufacturing

The biotech giant reported a bigger-than-expected quarterly loss.

Moderna's Q4 Loss Wider Than Expected @themotleyfool #stocks $MRNA

The biopharma reported disappointing fourth-quarter results, missing bottom line estimates amid a steep decline in COVID-19 vaccine sales.

Moderna beats on revenue but loses more than expected as it scales down manufacturing

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the decline of its Covid business.

Moderna GAAP EPS of -$2.91 misses by $0.15, revenue of $966M beats by $24.86M (NASDAQ:MRNA)

Moderna (MRNA) reports Q4 GAAP EPS of -$2.91, misses by $0.15, but beats revenue estimates with $966M.

Moderna beats on revenue but loses more than expected as it scales down manufacturing – DG Verifications & Stats

In this article MRNA Follow your favorite stocksCREATE FREE ACCOUNTThe Moderna Inc. headquarters in Cambridge, Massachusetts, on March 26, 2024.Adam Glanzman | Bloomberg | Getty Images Moderna on Friday posted fourth-quarter revenue that beat estimates, but lost more than expected for the period, as the biotech company continues to slash costs and demand for its Covid vaccine falls.  It marks another quarter of growing pains for the company, wh…

Moderna beats on revenue but loses more than expected as it scales down manufacturing - Daily news Update

Moderna on Friday posted fourth-quarter revenue that beat estimates, but lost more than expected for the period, as the biotech company continues to slash costs and demand for its Covid vaccine falls.  It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the rapid decline of its once-booming Covid business.  Shares of Moderna fell more than 4% in premarket trading Friday. Moderna post…